Showing results (421-430 of 1,188) with videos related to
Sort By:
Pageof 119
Pharmaceutical Statistics|September 30, 2011
Active controlled studies in antibiotic drug developmentAaron DanePharmaceutical Statistics|September 21, 2011
Issues in the assessment of non-inferiority: perspectives drawn from case studiesH Ulrich Burger, Ulrich Beyer, Markus AbtPharmaceutical Statistics|March 14, 2012
A general method to determine sampling windows for nonlinear mixed effects models with an application to population pharmacokinetic studiesLee Kien Foo, James McGree, Stephen DuffullPharmaceutical Statistics|August 25, 2018
Exact and asymptotic tests under the sequential parallel comparison designKung-Jong LuiPharmaceutical Statistics|August 17, 2018
A Bayesian hierarchal modeling approach to shortening phase I/II trials of anticancer drug combinationsShinjo Yada, Chikuma HamadaPharmaceutical Statistics|August 17, 2018
Effect of a statistical outlier in potency bioassaysPerceval Sondag, Lingmin Zeng, Binbing Yu, et al.Pharmaceutical Statistics|February 10, 2010
The impact of period effects on dose level contrasts in alternating cross-over designs for first-time-in-human studiesStephan Koehne-Voss, Heinz Schmidli, David M Smith, et al.Pharmaceutical Statistics|February 27, 2010
An alternative phase II/III design for continuous endpointsWong-Shian Huang, Jen-pei Liu, Chin-Fu HsiaoPharmaceutical Statistics|January 16, 2010
Graphical displays for clarifying how allocation ratio affects total sample size for the two sample logrank testBenjamin R Saville, Yong S Kim, Gary G KochPharmaceutical Statistics|December 31, 2009
Confirmatory analysis for phase III population pharmacokineticsChuanpu Hu, Ji Zhang, Honghui ZhouPageof 119